Scientists hunt for early warning signs of devastating nerve disease
NCT ID NCT07213440
Summary
This study aims to find biological markers that could help doctors diagnose ALS much earlier, before major symptoms appear. Researchers will compare blood, urine, and spinal fluid from 60 people, including those with a genetic risk but no symptoms, early ALS patients, and healthy volunteers. The goal is to create a molecular 'fingerprint' that could lead to earlier detection and better future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS (ALS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Tours
RECRUITINGTours, France, 37000, France
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.